Patents by Inventor Sarjana Dutt

Sarjana Dutt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug comprising synthetic peptide analogs for the treatment of cancer
    Patent number: 7781398
    Abstract: The present invention relates to a combination of peptides that may be used for treatment of cancer. The peptide combination competes for the binding of specific neuropeptides at the plasma membrane and thereby alters the levels of key intracellular molecules implicated in cell proliferation, resulting in a broad spectrum of anticancer activity. The invention also relates to pharmaceutical compositions containing a combination of such peptide analogs.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: August 24, 2010
    Assignee: Dabur Pharma Ltd.
    Inventors: Rama Mukherjee, Anand C. Burman, Anu T. Singh, Manu Jaggi, Sudhanand Prasad, Sarjana Dutt
  • Drug comprising synthetic peptide analogs for the treatment of cancer
    Publication number: 20070093422
    Abstract: The present invention relates to a combination of peptides that may be used for treatment of cancer. The peptide combination competes for the binding of specific neuropeptides at the plasma membrane and thereby alters the levels of key intracellular molecules implicated in cell proliferation, resulting in a broad spectrum of anticancer activity. The invention also relates to pharmaceutical compositions containing a combination of such peptide analogs.
    Type: Application
    Filed: December 21, 2006
    Publication date: April 26, 2007
    Applicant: DABUR RESEARCH FOUNDATION
    Inventors: Rama Mukherjee, Anand Burman, Anu Singh, Manu Jaggi, Sudhanand Prasad, Sarjana Dutt
  • Drug comprising synthetic peptide analogs for the treatment of cancer
    Patent number: 7173006
    Abstract: The present invention relates to a combination of peptides that may be used for treatment of cancer. The peptide combination competes for the binding of specific neuropeptides at the plasma membrane and thereby alters the levels of key intracellular molecules implicated in cell proliferation, resulting in a broad spectrum of anticancer activity. The invention also relates to pharmaceutical compositions containing a combination of such peptide analogs.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: February 6, 2007
    Assignee: Dabur Research Foundation
    Inventors: Rama Mukherjee, Anand C. Burman, Anu T. Singh, Manu Jaggi, Sudhanand Prasad, Sarjana Dutt
  • Drug comprising synthetic peptide analogs for the treatment of cancer
    Publication number: 20040121950
    Abstract: The present invention relates to a combination of peptides that may be used for treatment of cancer. The peptide combination competes for the binding of specific neuropeptides at the plasma membrane and thereby alters the levels of key intracellular molecules implicated in cell proliferation, resulting in a broad spectrum of anticancer activity. The invention also relates to pharmaceutical compositions containing a combination of such peptide analogs.
    Type: Application
    Filed: December 23, 2002
    Publication date: June 24, 2004
    Applicant: DABUR RESEARCH FOUNDATION
    Inventors: Rama Mukherjee, Anand C. Burman, Anu T. Singh, Manu Jaggi, Sudhanand Prasad, Sarjana Dutt
  • Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
    Patent number: 6608174
    Abstract: The present invention encompasses radiolabeled peptide analogs of vasoactive intestinal peptide (VIP) labeled with a radionuclide useful for imaging target sites within mammalian living systems. The invention particularly provides radiolabeled VIP derivatives that bind selectively to the VIP receptor on target cells. Specifically, the invention relates to the radiolabeling of VIP-receptor specific agents and their subsequent use for radiodiagnostic and radiotherapeutic purposes. The invention encompasses methods for radiolabeling these peptides with radio-nuclides and the use of these peptides as scintigraphic imaging agents.
    Type: Grant
    Filed: July 31, 2000
    Date of Patent: August 19, 2003
    Assignee: Dabur Research Foundation
    Inventors: Anand C. Burman, Sudhanand Prasad, Rama Mukherjee, Sarjana Dutt, Rajan T. Sharma, Rinku Ahuja, Anil K. Mishra, Lazar T. Mathew